Clinical Trial

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 15, 2026 (before its estimated May 23, 2026 completion). Its status may not reflect the trial's current state.
Summary
Radiation dermatitis is a common complication in head and neck squamous cell carcinoma patients receiving radiotherapy. This study proposes an ROS-scavenging amino acid-based nanolipid to prevent oxidative skin damage. A multicenter randomized trial will evaluate its safety and efficacy in reducing dermatitis severity and improving treatment continuity.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-15; most recent amendment 2026-04-14.
Status change: Not Yet Recruiting → Recruiting 2025-07-24
Trial Details
NCT Number NCT07081074
Lead Sponsor West China Hospital
Conditions Radiation Dermatitis
Enrollment 40 participants
Start Date 2025-07-23
Primary Completion 2026-05-23 (estimated)
Study Completion 2026-12-23 (estimated)
Updated on ClinicalTrials.gov 2026-04-15